present
work
aim
design
synthes
novel
seri
spiro
analogu
investig
bioactiv
antioxid
antimicrobi
agent
well
antiprolif
potenc
select
human
cancer
cell
line
ie
breast
colon
liver
rel
healthi
noncancer
control
skin
fibroblast
cell
mechan
cytotox
activ
also
examin
immunoassay
level
key
antiand
proapoptot
protein
marker
analyt
spectral
data
synthes
target
congen
compat
structur
synthes
compound
show
divers
moder
power
antimicrobi
antioxid
activ
result
mtt
assay
reveal
seven
synthes
compound
ie
particularli
exhibit
signific
cytotox
three
cancer
cell
line
investig
rang
ic
valu
obtain
respect
base
least
ic
valu
signific
rel
refer
chemotherapeut
drug
doxorubicin
cell
analogu
exhibit
highest
cytotox
ic
valu
rel
doxorubicin
ic
observ
cytotox
specif
cancer
cell
evidenc
minim
toxic
noncancer
control
skinfibroblast
cell
elisa
result
indic
observ
antiprolif
effect
examin
cancer
cell
line
mediat
via
engag
activ
apoptosi
illustr
signific
increas
proapoptot
protein
marker
bax
reduct
antiapoptot
marker
taken
togeth
result
present
studi
emphas
potenti
spiro
pyrazoleoxindol
analogu
valuabl
candid
anticanc
agent
human
cancer
cell
cancer
primari
global
burden
diseas
classifi
secondlead
caus
death
cardiovascular
diseas
toxic
current
avail
repertoir
anticanc
drug
ineffici
chemotherapi
two
major
limit
battl
cancer
therefor
design
discov
effect
select
antitumor
agent
remain
primari
object
organ
medic
chemistri
known
target
therapeut
strategi
one
strategi
apoptosi
aka
program
cell
death
consid
essenti
mechan
bodi
elimin
unwant
cell
therefor
trigger
apoptosi
cancer
cell
lead
immedi
death
therebi
increas
control
cancer
prolifer
method
understand
mechan
apoptosi
disclos
influenc
express
caspas
famili
protein
includ
either
antiapoptot
proapoptot
member
induct
apoptosi
consid
one
success
strategi
target
cancer
isatin
deriv
promis
class
heterocycl
molecul
divers
biolog
activ
interest
common
applic
isatin
organ
synthesi
primarili
focus
highli
reactiv
carbonyl
group
vast
major
reaction
carbonyl
group
isatin
nucleophil
addit
spiroannul
transform
deriv
end
particularli
spirofus
cyclic
frame
attract
signific
research
interest
disciplin
synthet
organ
chemistri
medicin
chemistri
repres
core
structur
varieti
natur
product
drug
isomitraphyllin
isocorynoxin
isorhnchophllin
mitraphyllin
uncarin
interestingli
spirocycl
oxindol
spirooxindol
combin
rigid
heterocycl
ring
oxindol
core
efficaci
class
small
molecul
inhibit
cell
prolifer
induc
apoptosi
cancer
cell
lead
tumor
growth
regress
without
affect
normal
cell
exampl
document
oxindol
alkaloid
deriv
root
bark
uncaria
tomentosa
plant
exhibit
apoptosismedi
cytotox
acut
lymphoblast
leukaemia
cell
context
object
current
studi
threefold
design
synthes
novel
seri
spiro
analogu
ii
evalu
antimicrobi
antioxid
antiprolif
bioactiv
three
cancer
cell
line
type
ie
iii
determin
underli
mechan
induc
apoptosi
cancer
cell
simpl
conveni
rout
synthesi
substitut
acid
sum
figur
differ
aryl
methyl
keton
name
methyl
keton
prepar
start
materi
studi
aldol
condens
isatin
aryl
methyl
keton
presenc
catalyt
amount
diethylamin
stir
approxim
day
room
temperatur
yield
result
aldol
product
aryl
compound
also
form
reaction
carri
presenc
drop
diethylamin
reflux
h
gave
product
ident
aspect
mp
admix
mp
differ
yield
acid
dehydr
latter
compound
use
glacial
acet
acid
contain
drop
conc
hcl
afford
correspond
molecular
hybrid
aryl
respect
cycliz
compound
upon
heat
hydrazin
hydrat
dri
ethanol
presenc
drop
glacial
acet
acid
catalyst
yield
consequ
deriv
meanwhil
cycliz
hydrazin
hydrat
andor
phenyl
hydrazin
base
aboveprovid
method
produc
correspond
respect
side
reaction
isatin
andor
action
aqueou
potassium
hydroxid
pfitzing
condit
result
open
ring
isatin
recycl
give
carboxyl
acid
correspondingli
analyt
spectral
data
entir
target
compound
compat
structur
see
experiment
part
newli
synthes
compound
chosen
evalu
vitro
toward
varieti
pathogen
microorgan
gramposit
bacteria
aureu
atcc
b
subtili
atcc
gramneg
bacteria
p
areuginosa
atcc
e
coli
dsmz
yeast
c
albican
atcc
cerevisia
atcc
fungi
niger
nrrl
use
disk
diffus
method
singl
dose
result
shown
tabl
growth
inhibit
zone
mm
compound
exhibit
potent
activ
c
albican
cerevisia
inhibit
zone
mm
compar
refer
drug
amphotericin
b
mm
besid
show
signific
inhibit
zone
mm
respect
toward
c
albican
meanwhil
potent
activ
growth
inhibit
zone
mm
higher
refer
drug
amphotericin
b
mm
toward
c
albican
hand
compound
result
signific
growth
inhibit
zone
mm
respect
b
subtili
compar
refer
drug
amoxicillin
growth
inhibit
zone
mm
reveal
signific
activ
p
areuginosa
growth
inhibit
zone
mm
respect
compar
ciprofloxacin
zone
inhibit
valu
mm
tabl
rest
test
compound
exhibit
trivial
effect
pathogen
microorgan
investig
antioxid
activ
newli
synthes
assess
term
hydrogendon
radicalscaveng
abil
via
stabl
free
radic
dpph
use
ascorb
acid
refer
concentr
result
indic
abil
test
compound
reduc
solut
violet
dpph
radic
render
colorless
increas
min
compound
exhibit
moder
free
radicalscaveng
effect
min
rang
compar
ascorb
acid
notabl
compound
reveal
potent
free
radicalscaveng
activ
min
equival
respect
compar
given
standard
solut
ascorb
acid
tabl
tabl
scaveng
activ
dpph
radic
activ
compound
concentr
newli
synthes
compound
screen
antiprolif
activ
human
breast
cancer
human
colon
cancer
human
liver
cancer
well
normal
skin
fibroblast
cell
vitro
mtt
assay
tabl
obtain
result
indic
congen
investig
exhibit
select
cytotox
cell
line
compar
refer
doxorubicin
antiprolif
activ
rang
minim
cytotox
observ
normal
skin
fibroblast
cell
refer
cell
compound
show
potent
antiprolif
activ
rang
compar
posit
control
drug
doxorubicin
except
compound
exhibit
low
antiprolif
activ
within
rang
regard
cancer
cell
line
compound
investig
show
potent
antiprolif
activ
rang
interestingli
test
analogu
reveal
minim
inhibit
effect
rang
normal
skin
fibroblast
cell
except
compound
find
encourag
belief
compound
possess
high
select
cancer
cell
high
safeti
margin
normal
cell
therebi
highlight
util
potent
safe
anticanc
drug
studi
tabl
antiprolif
activ
newli
synthes
compound
human
carcinoma
cell
line
normal
skin
fibroblast
cell
hct
doserespons
cytotox
curv
select
drug
potent
antiprolif
activ
ie
refer
line
depict
figur
concentr
requir
inhibit
cell
viabil
ic
calcul
activ
compound
exhibit
low
toxic
cell
use
doxorubicin
refer
drug
tabl
interestingli
ic
valu
compound
shown
evid
potent
refer
doxorubicin
ic
cancer
cell
line
activ
descend
order
ic
respect
moreov
data
reveal
compound
induc
highest
cytotox
cancer
cell
line
ic
compar
refer
doxorubicin
ic
hand
test
compound
found
exhibit
potent
cytotox
ic
valu
rang
toward
cancer
cell
line
rel
refer
doxorubicin
ic
potent
drug
exhibit
ic
valu
respect
promis
antiprolif
result
report
compound
cell
line
studi
prompt
us
investig
mechan
cell
death
induc
compound
apoptosi
induct
examin
cancer
cell
assay
level
key
protein
marker
name
proapoptot
bcl
x
bax
antiapoptot
bcell
cell
undergo
apoptosi
detect
use
elisa
techniqu
protein
marker
level
quantifi
accord
bradford
assay
result
indic
compound
significantli
reduc
express
level
antiapoptot
protein
respect
toward
cell
compar
control
tabl
meanwhil
treatment
cell
compound
conspicu
reduc
express
level
antiapoptot
protein
respect
compar
control
tabl
cell
apoptosi
sophist
meticul
regul
biolog
process
associ
complex
signal
pathway
respons
caspas
group
cysteineaspart
acid
proteas
play
pivot
role
execut
intracellular
regul
apoptosi
key
execution
apoptosi
activ
extrins
death
ligand
intrins
mitochondri
dysfunct
hand
tumor
suppressor
protein
posit
regul
x
bax
death
promot
bad
homolog
antagonistkil
bak
proapoptot
protein
prevent
captur
free
bax
bad
bak
subsequ
bind
mitochondri
membran
induc
mitochondri
damag
cell
apoptosi
zhang
cowork
demonstr
promot
transcript
bax
bak
regul
releas
cytochrom
c
mitochondria
result
cell
apoptosi
activ
cleav
therefor
increas
express
bax
caus
increas
protein
express
level
activ
present
studi
treatment
cell
compound
result
signific
elev
activ
protein
level
fold
respect
compar
control
line
previou
compound
increas
express
level
proapoptot
bax
compar
control
addit
treatment
cell
compound
gave
rise
protein
level
fold
respect
compar
control
well
increas
express
proapoptot
protein
bax
compar
control
despit
compound
increas
express
activ
bax
protein
caus
increas
protein
level
result
suggest
addit
yet
undefin
regulatori
mechan
might
present
finetun
apoptosi
induct
treatment
tabl
merit
investig
context
evid
correl
magnitud
elev
ratio
proport
upregul
found
correl
regard
key
signal
trigger
execut
apoptosi
cancer
cell
therebi
lead
observ
potent
antiprolif
activ
mtt
assay
conclus
present
work
highlight
potenti
applic
novel
seri
spiro
power
synthet
antiprolif
agent
act
via
induct
apoptosi
cancer
cell
line
thorough
investig
warrant
order
fulli
explor
spectrum
cytotox
novel
spiro
analogu
batteri
cancer
cell
line
well
vivo
biolog
activ
experiment
anim
model
unless
otherwis
state
chemic
includ
mtt
bromid
purchas
sigma
aldrich
st
loui
mo
usa
fb
lglutamin
penicillinstreptomycin
obtain
hyclon
laboratori
logan
ut
usa
reagent
solvent
analyt
grade
melt
point
determin
digit
melt
point
apparatu
electro
thermal
electro
thermal
engin
ltd
serial
rochford
unit
kingdom
uncorrect
reaction
progress
monitor
thinlay
chromatographi
tlc
use
silica
gel
plate
polygram
mm
visual
uv
light
nm
element
analys
carri
perkinelm
analyz
perkinelm
perkinelm
inc
waltham
unit
state
found
within
theoret
valu
ir
spectra
implement
beckman
infrar
spectrophotomet
pu
use
kbr
disk
h
c
nmr
spectra
measur
bruker
advanc
spectromet
bruker
germani
mhz
respect
use
tm
intern
standard
chemic
shift
repres
part
per
million
ppm
rel
solvent
peak
mass
spectra
ei
record
jeol
jmsax
ei
jeol
ltd
musashino
akishima
tokyo
japan
ml
diethylamin
mmol
ad
reaction
mixtur
stir
room
temperatur
approxim
day
solid
form
filter
wash
water
airdri
use
next
step
without
purif
case
compound
product
obtain
stir
room
temperatur
left
overnight
method
b
solut
isatin
mmol
aryl
methyl
keton
mmol
absolut
ethanol
ml
contain
diethylamin
mmol
heat
reflux
h
progress
reaction
monitor
use
tlc
reaction
accomplish
reaction
mixtur
cool
solid
form
filter
wash
water
airdri
use
next
step
without
purif
solut
compound
mixtur
glacial
acet
acid
ml
two
drop
concentr
hcl
heat
c
min
cool
reaction
mixtur
quench
icewat
solid
form
filter
wash
water
airdri
crystal
ethyl
acetatecyclohexan
mixtur
compound
mmol
hydrazin
hydrat
mmol
absolut
ethanol
ml
drop
glacial
acet
acid
ad
reaction
mixtur
reflux
h
cool
reaction
mixtur
pour
onto
icewat
solid
form
filter
wash
water
airdri
crystal
ethyl
acetatecyclohexan
compound
prepar
accord
previous
describ
method
compound
use
equimolar
mixtur
compound
mmol
phenyl
hydrazin
mmol
free
radic
scaveng
activ
rsa
assess
spectrophotomet
nm
via
decolor
solut
dpph
radic
accord
brandwilliam
et
al
dpph
solut
prepar
dissolv
mg
dpph
one
liter
dimethylsulphoxid
dmso
freshli
prepar
dpph
solut
use
assay
test
compound
b
dissolv
dmso
volum
dmso
stock
solut
test
compound
ad
ml
freshli
prepar
dpph
dmso
solut
mixtur
shaken
vortex
rpm
min
left
stand
min
dark
room
absorb
measur
nm
blank
use
uv
visibl
spectrophotomet
pc
shimadzu
kyoto
japan
lower
absorb
reaction
mixtur
indic
higher
free
radic
scaveng
activ
analyz
graph
plot
inhibit
percentag
compound
concentr
experi
carri
triplic
averag
scaveng
activ
calcul
accord
follow
formula
scaveng
abil
control
sampl
control
cell
cultur
human
breast
cancer
human
colon
cancer
human
liver
cancer
cell
line
obtain
karolinska
institut
stockholm
sweden
cell
maintain
rpmi
medium
media
supplement
heatinactiv
fetal
bovin
serum
plu
antibioticantimycoticmixtur
uml
potassium
penicillin
streptomycin
sulfat
amphotericin
b
l
glutamin
biowest
usa
human
skin
fibroblast
deriv
normal
foreskin
obtain
atcc
frozen
ampoul
cell
per
ml
volum
maintain
mem
mm
lglutamin
earl
salt
medium
cell
viabil
studi
use
mtt
bromid
bio
basic
canada
inc
toronto
canada
assay
step
execut
steril
laminar
air
flow
cabinet
biosafeti
class
ii
level
baker
sanford
usa
incub
carri
c
co
incub
humidifi
atmospher
sheldon
corneliu
usa
cell
seed
microtit
plastic
plate
concentr
cellswel
allow
adher
h
medium
aspir
ad
cell
test
compound
b
singl
dose
dmso
incub
medium
h
mtt
salt
ad
well
incub
addit
h
stop
reaction
dissolv
form
formazan
crystal
sodium
dodecyl
sulfat
sd
ad
well
incub
overnight
c
amount
formazan
product
measur
nm
refer
wavelength
nm
background
use
micropl
reader
biorad
laboratori
model
california
usa
untreat
cell
neg
control
medium
ad
instead
test
compound
posit
control
adrinamycin
doxorubicin
mr
pharmacia
india
pvt
ltd
gurgaon
haryana
india
use
known
cytotox
natur
agent
give
inhibit
dimethylsulfoxid
dmso
vehicl
use
dissolut
test
compound
final
concentr
cell
less
dilut
solvent
concentr
drug
control
drug
treatment
concentr
requir
inhibit
cell
viabil
ic
calcul
potent
compound
show
preliminari
cytotox
effect
appli
variou
concentr
three
replic
per
concentr
group
test
compound
employ
probit
analysi
method
use
simpl
ttest
spss
statist
analysi
softwar
packagevers
spss
inc
il
chicago
usa
cellular
apoptosi
protein
marker
analyz
treatment
ic
character
relev
antiprolif
activ
previous
briefli
cell
hct
seed
concentr
cellswel
plate
treatment
collect
cell
lyse
centrifug
rpm
min
c
protein
concentr
measur
supernat
bradford
protein
assay
volum
contain
mg
total
protein
incub
ml
caspas
substrat
ml
reaction
buffer
c
h
dark
activ
determin
micropl
reader
nm
use
colorimetr
assay
kit
abcam
accord
manufactur
instruct
vitro
protein
level
quantit
measur
apoptot
marker
x
bax
antiapoptot
marker
bcell
cell
lysat
assess
enzymelink
immunosorb
assay
simpl
step
elisa
abcam
accord
manufactur
instruct
data
present
mean
sd
individu
group
compar
use
twotail
independ
student
ttest
multipl
group
comparison
carri
use
oneway
analysi
varianc
anova
follow
tukeykram
test
posthoc
analysi
